Carrie B Hruska

Title: Innovations in Molecular Breast Imaging by Carrie B Hruska

Introduction

Carrie B Hruska is a notable inventor based in Rochester, MN (US), recognized for her contributions to the field of molecular breast imaging. With a total of 3 patents, her work focuses on enhancing the accuracy and effectiveness of breast cancer diagnostics.

Latest Patents

One of her latest patents is titled "System and method for quantitative molecular breast imaging." This innovative system allows for quantitative lesion analysis in molecular breast imaging (MBI) by utilizing opposing images of a slightly compressed breast obtained from a dual-head gamma camera. The method determines tumor diameter by analyzing the shape of pixel intensity profiles through each tumor. Additionally, it assesses the thickness of the compressed breast and the attenuation of gamma rays in soft tissue to ascertain the tumor's depth from the detector head. The method also calculates the relative radiotracer uptake or tumor-to-background ratio (T/B ratio) using the measured tumor diameter and counts in both the tumor and background breast region.

Another significant patent is "System and method for tumor analysis and real-time biopsy guidance." This system enhances tumor analysis and provides real-time biopsy guidance through molecular breast imaging (MBI). It includes a detector head with a gamma ray detector and a collimator featuring multiple collimation sections with different spatially-oriented structures. The system is designed to acquire updatable images, offering real-time feedback during biopsy procedures.

Career Highlights

Carrie B Hruska is affiliated with the Mayo Foundation for Medical Education and Research, where she continues to innovate in the field of medical imaging. Her work has significantly impacted the way breast cancer is diagnosed and treated, providing healthcare professionals with advanced tools for better patient outcomes.

Collaborations

Throughout her career, Carrie has collaborated with esteemed colleagues such as Michael K O'Connor and Amanda L Weinmann, contributing to the advancement of molecular imaging technologies.

Conclusion

Carrie B Hruska's innovative patents and dedication to improving breast cancer diagnostics exemplify her commitment to advancing medical technology. Her contributions are paving the way for more effective and accurate diagnostic methods in the field of oncology.